ArticleAmerican journal of translational research2021
A comparison of the multimodal magnetic resonance imaging features of brain metastases vs. high-grade gliomas.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
- FLAIR-based radiomics signature from brain-tumor interface for early prediction of response to EGFR-TKI therapy in NSCLC patients with brain metastasis.Frontiers in cell and developmental biology · 2025Article
- Natural language processing deep learning models for the differential between high-grade gliomas and metastasis: what if the key is how we report them?European radiology · 2024Article
- Diagnostic Value of Multimodal Magnetic Resonance Imaging in Discriminating Between Metastatic and Non-Metastatic Pelvic Lymph Nodes in Cervical Cancer.International journal of general medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe aimed to explore the multimodal magnetic resonance imaging (MRI) features of brain metastases and high-grade brain gliomas.
methodsFifty patients with brain metastases and 28 patients with high-grade gliomas treated in the neurosurgery department of our hospital were selected for this study. All patients underwent routine MRI, diffusion tensor imaging, and perfusion-weighted magnetic resonance imaging. The average diffusion coefficient (ADC), fractional anisotropy (FA), regional cerebral blood flow (rCBF), and regional cerebral blood volume (rCBV) in the tumor parenchyma, peritumoral edema area, and the contralateral normal cerebral white matter were compared between the patients with brain metastases and the patients with high-grade brain gliomas.
resultsThere were differences in the degree of peritumoral edema between the two groups of patients (P = 0.017). Compared with the patients with high-grade gliomas, the patients with brain metastases had lower FA values in the tumor parenchyma area, higher ADC values in the peritumoral edema area, and lower rCBV and rCBF values in the peritumoral edema area (all P<0.001).
conclusionThe measurement of the ADC, rCBV, and rCBF values in the peritumoral edema area and the FA values in the tumor parenchyma area using multimodal MRI can have essential clinical value in the differentiation between brain metastases and high-grade gliomas.
Indexed as
Identifiers
34017534PMC8129411W3162422912What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.